SIMULTANEOUS IDENTIFICATION AND QUANTIFICATION OF HYDROQUINONE, TRETINOIN AND BETAMETHASONE IN COSMETIC PRODUCTS BY ISOCRATIC REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY by maggadani, baitha PALANGGATAN et al.
 
 
SIMULTANEOUS IDENTIFICATION AND QUANTIFICATION OF HYDROQUINONE, TRETINOIN AND 




BAITHA PALANGGATAN MAGGADANI, HARMITA, YAHDIANA HARAHAP, HANA LILI NATASYA HUTABALIAN 
Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia 
Email: baitha.p@farmasi.ui.ac.id 
Received: 06 Feb 2019, Revised and Accepted: 06 Apr 2019 
ABSTRACT  
Objective: The objective of this study was to obtain a simple and selective analysis method for determination of hydroquinone, tretinoin and 
betamethasone in whitening creams using reversed-phase high-performance liquid chromatography (HPLC).  
Methods: Reverse Phase HPLC was used for method development, validation studies, and sample analysis. The method was optimized by evaluating 
several parameters that affects the extraction of the sample, composition and types of mobile phase and also flow rate. Chromatographic separation 
was optimized on a C18 column [Sunfire, 250 x 4.6 mm, 5 µm] utilizing a mobile phase consisting acetonitrile, methanol (90:10 v/v) and slightly 
addition of glacial acetic acid to reach pH 5in the ratio of 30: 50:20 v/v at a flow rate of 0.8 ml/min with UV detection at 270 nm and 350 nm. 
Results: The analytical methods fulfilled the validation requirements including accuracy, precision, linearity, selectivity, detection limits, and 
quantitation limits. The results showed the mean levels of hydroquinone, tretinoin and betamethasone in samples A and B were 1.78%; 0.07%; 
0.12% and 2.00%; 0.07%; 0.13% respectively.  
Conclusion: The method was successfully applied for the determination of cosmetic formulation containing hydroquinone, tretinoin and betamethasone 
simultaneously. There were seven samples analyzed and two samples were positive containing hydroquinone, tretinoin, and betamethasone. 
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Skin whitening cream is a type of cosmetic product that is now popular 
in many countries in Africa and Asia [1-3]. For most women in Indonesia, 
beauty defined with clear, spotless, white and bright skin. Therefore, the 
presence of brownish spots is considered to interfere with the concept. 
Although the spot is not harmful to health, many people often try to 
eliminate it. Some skin whitening products are claimed to contain a 
variety of highly toxic active ingredients especially after prolonged 
applications, such as hydroquinone, tretinoin, and corticosteroids [2][4-
5]. The whitening agent may trigger harmful local effects such as skin 
burning, ochronosis, irritant contact dermatitis, leukoderma (vitiligo), 
post-inflammatory hyperpigmentation, and systemic toxicity, especially 
for the liver and kidneys [6]. In 2008, the Indonesian Food and Drug 
Administration also prohibited the use of hydroquinone, tretinoin, and 
betamethasone in cosmetic whitening products [7].  
Several methods have been developed for the analysis of hydroquinone, 
tretinoin and betamethasone in illegal whitening creams. Analysis of 
hydroquinone in whitening cream has been developed using thin layer 
chromatography (TLC) and UV-Vis spectrophotometry [8-10]. 
Furthermore, high-performance liquid chromatography or HPLC 
methods have also been developed to analyze the hydroquinone and 
tretinoin content in cosmetics of physician prescription cream [11, 12]. 
Gas chromatography-mass spectrometry (GC-MS) method also have 
been developed to determine skin whitening agent in cosmetic products 
[13]. Another HPLC method also has been described by Desmedt (2013) 
to screen and quantify legal and illegal skin bleaching agent [6]. 
None of the above research methods performed simultaneous 
hydroquinone, tretinoin and betamethasone analyze using a simple 
isocratic HPLC method. So, this study was aimed to develop 
simultaneous, rapid, and selective analysis method towards these three 
harmful active substances in whitening cream using HPLC with some 
optimization. This HPLC method was preferred because of its high 
sensitivity, relatively simple implementation, efficient, good separation, 
analysis can be done in a relatively short time and also reproducible [14]. 
MATERIALS AND METHODS 
Instrumentation 
High Performance Liquid Chromatography LC 20AT (Shimadzu, 
Japan) equipped with pump, SunFireTM C18 column, UV-VIS 
detector SPD-10A (Shimadzu, Japan), manual injector, and data 
processor (LC-Solution), Syringe HPLC (SGE, Australia), UV-Vis 
Spectrophotometry (Jasco V-530), centrifuge (Labofuge 5100), 
vortex (Thermo Scientific), Micropipette (Eppendorf), pH meters 
(Eutech Instruments pH 510), sonicator UltrasoniC, hotplate (IKA® 
C-MAG HS 7), Whatman filter membrane diameter 0.45 μm, 
Whatman filter paper no. 41, ovens, desiccators, analytical scales, 
volumetric pipettes, rubber balloons, and glassware. 
Materials 
Hydroquinone, tretinoin, and betamethasone (Merck). Methanol and 
acetonitrile HPLC Grade (Merck), aquabidestilata (Ikapharmindo). 
Seven samples of whitening cream used are listed below table 1 
 
Table 1: Skin whitening cream sample information 
Sample Origin Source 
A No name and country of manufacturer information Social media (Instagram) 
B No name and country of manufacturer information Social media (Instagram) 
C Local manufacturer Public market 
D Local manufacturer Traditional market 
E Local manufacturer Department store 
F Local manufacturer Department store 
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Standard solution preparation 
Standard solution of hydroquinone, betamethasone, and tretinoin 
were prepared using acetonitrile to obtain a final concentration of 
1000 μg/ml. The mixture was filtered through a 0.45 μm membrane 
filter and stored in the refrigerator until to be used. 
Sample solution preparation 
Approximately, 1 g of cream sample was extracted using 10 ml of 
acetonitrile and add 0.1% glacial acetic acid P into acetonitrile. The 
mixture was put into heating over the water bath at 40-60 °C and 
stirred thoroughly using magnetic stirrer until perfectly dissolved. 
Centrifugation was performed at 4000 rpm for 15 min. The 
supernatant was filtered through a 0.45 μm filter membrane to 
separate the undissolved matter. The filtrate was collected in a 25 
ml volumetric flask wrapped in aluminum foil and ad with 
acetonitrile.  
Optimization of the analysis condition 
The analysis parameters that need to be optimized were 
combination and composition of mobile phase, flow rate and 
wavelength of analysis. The optimization was done by injecting 20 μl 
of standard solution into HPLC. Table 2 showed the variation of 
mobile phase combination. Flow rate variation were ranged 
between 0,8-1,2 ml/min. The optimum analysis conditions were 
assessed by the separation between two adjacent peaks or 
resolution (R), peak sharpness, analytical area, Tf, retention time, 
column efficiency (HETP) and the number of theoretical plates (N). 
 
Table 2: Selection of optimal mobile phase 
No Mobile phase Composition 
1 Acetonitrile–Phosphate buffer pH 6 (90:10) v/v 
2 Acetonitrile–Water–TEA (90:10:0,5) v/v/v 
3 Acetonitrile–Methanol–Ethyl acetate (60:25:15) v/v 
4 Acetonitrile–Methanol (50:50) v/v 
5 Acetonitrile–Methanol (70:30) v/v 
6 Acetonitrile–Methanol (90:10) v/v 
Note: No. 4-6 added glacial acetic acid (pH modifier) until the solution reaches pH 5. 
 
System suitability test 
A standard mixed solution (10 μg/ml) was injected as much as 20 μl into 
the HPLC with selected analysis conditions. 6 repeated injection was 
done to ensure a constant peak area. The injection result was recorded 
and the coefficient of variation was counted (% CV). The % CV value 
should be ≤ 2%. The parameters were based on the separation between 
two adjacent peaks (R), tailing factor, retention time, column efficiency 
(HETP) and the number of theoretical plates (N). 
Validation of analysis methods 
Preparation of calibration curve and linearity test 
The calibration curve test solution was prepared by diluting the 
standard solution of hydroquinone, tretinoin and betamethasone 
with the range of 75-300μg/ml for hydroquinone; 0.5-5 μg/ml for 
tretinoin and 1-20 μg/ml for betamethasone. 20 μl of each 
concentration level was injected into HPLC with selected analysis 
conditions. The ICH requirement value of correlation coefficient is ≥ 
0.999 as shown in fig 1-3. 
 
 
Fig. 1: Hydroquinone calibration curve 
 
Detection limit test (LOD) and quantitation limit (LOQ) 
From the obtained calibration curve, calculated the least detectable 
concentration (LOD) and quantitatively detected (LOQ) using a 
statistical calculation of the linear regression equation of the 
calibration curve. Limit detection and quantitation limits were 
calculated by measuring the blank response several times then 
calculated the standard deviation of the blank. The standard 
deviation of the blank (Sb) is equal to the residual standard 
deviation (Sy/x) [15]. 
 
 
Fig. 2: Betamethasone calibration curve 
 
 
Fig. 3: Tretinoin calibration curve 
 
Selectivity test 
20 μl of 100 μg/ml standard solution, Standard mixed solutions of 
hydroquinone, tretinoin and betamethasone (100 μg/ml) were 
injected 20 μl into HPLC with selected analysis conditions. 
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Interferences were evaluated by comparing chromatogram of matrix 
solution and standard solution.  
Accuracy and precision 
20 μl of 100 μg/ml standard solution, Standard mixed solutions of 
hydroquinone, tretinoin and betamethasone (100 μg/ml) were 
injected 20 μl into HPLC with selected analysis conditions. The 
accuracy is determined from the recovery of at least three different 
concentrations with three repetitions per concentration [16]. 
Precision was determined using a minimum of 6 determinations at 
100% of the test concentration.  
RESULTS  
Optimization of chromatographic analysis 
Combination of an acetonitrile-phosphate buffer as a mobile phase 
produced chromatogram with uneven baseline, the peak was not 
symmetrical and sharp. The area of the compound were small and 
not separated well. This chromatogram also occurred in 
combination 2, 3 and 4. The use of acetonitrile-methanol (90:10 v/v) 
as mobile phase resulted in the best chromatogram with better, 
sharper peak, larger area, faster retention time, and good resolution. 
Thus, this combination was used as a mobile phase for sample 
analysis.  
The starting wavelength value for the analysis of hydroquinone, 
betamethasone, and tretinoin was determined using 
Spectrophotometer. Maximum wavelength values obtained for 
hydroquinone was 294 nm, tretinoin 352 nm, and betamethasone 254 
nm. The maximum wavelength of tretinoin was far different from 
hydroquinone and betamethasone. The way to analysis 
simultaneously was by changing the maximum wavelength. The first 
wavelength used was 270 nm to determine hydroquinone and 
betamethasone. After both peak appeared, the maximum wavelength 
was changed into 352 nm for tretinoin determination. This method 
was successfully determined the three ingredients simultaneously. 
Flow rate selection 
The search for optimum conditions of flow rate was carried out at 
three different flow rates, ie 0.8 ml/min; 1.0 ml/min; and 1.2 
ml/min. the results of the optimization is shown in table 4: 
 
Table 3: Optimized wavelength optimization results of hydroquinone, tretinoin, and betamethasone 
Wavelength (nm) Compound Area (μV/s) RT (min) Tf HETP N R 
260 Hydroquinone 22671 2.687 1.289 21.772 6889.449 0.000 
Betamethasone 211589 3.085 1.220 25.027 5993.424 2.369 
Tretionin 1202236 6.321 0.871 12.590 11913.976 16.990 
270 Hydroquinone 50145 2.690 1.133 22.674 6615.575 0.000 
Betamethasone 88567 3.041 1.188 20.251 7407.101 2.514 
Tretionin 1206024 6.521 0.858 12.834 11687.345 17.784 
280 Hydroquinone 137321 2.702 1.242 18.951 7915.032 0.000 
Betamethasone 28470 3.024 1.512 29.523 5080.735 2.311 
Tretionin 1208625 6.450 0.862 12.467 12032.063 16.488 
 
Table 4: Optimized flow rate analysis of hydroquinone, tretinoin, and betamethasone 
Flow rate (ml/min) Compound Area (μV/s) RT (min) Tf HETP N R 
0.8 Hydroquinone 58116 3.376 1.210 19.942 7521.742 0.000 
Betamethasone 93130 3.783 1.180 17.164 8739.449 2.649 
Tretionin 1270690 8.072 0.811 11.477 13069.717 19.202 
1.0 Hydroquinone 50145 2.690 1.133 22.674 6615.575 0.000 
Betamethasone 88567 3.041 1.188 20.251 7407.101 2.514 
Tretionin 1206024 6.521 0.858 12,834 11687.345 17.784 
1.2 Hydroquinone 42543 2.249 0.000 36.075 4158.008 0.000 
Betamethasone 78786 2.531 0.000 35.120 4271.032 1.914 
Tretionin 1105425 5.371 0.881 13.824 10851.056 15.730 
 
Increasing the flow rate can result in faster retention times for all 
three compounds, but the resulting area is smaller and column 
pressure becomes higher. The faster the flow rate used then the 
resulting area will be smaller because the separation has not 
happened perfectly. In this study, a flow rate of 0.8 ml/min was 
chosen as the optimum flow rate because it resulted in a larger peak 
area, better resolution, column pressure at an optimum range, small 
HETP values, and the number of large theoretical plates. 
System suitability test 
Before the selected analysis is used for a study, it is necessary to first 
test the conformity of the system because of the possible variations 
in the equipment and the analytical techniques used. The results of 
repeatability test with injection as much as six times, obtained by 
follow-up factor of 1.403, HETP 18.381, number of theoretical plates 
8160.723, and a coefficient of 0.46% variation in hydroquinone 
compounds. In the tretinoin, compound obtained a factor of 0.854, 
HETP 11.185, the number of theoretical plates 13410.664, the 
coefficient of variation 0.75%. Furthermore, in the compound 
betamethasone obtained element follow up of 1.100, HETP 20.434, 
the number of theoretical plates 7340.564, the coefficient of 
variation 0.35%. The data table 5 meet the requirements of the 
system suitability test because the value of repetition or coefficient 
of variation is below 2%. 
 
Table 5: System suitability result 
  Tf HETP N R Standard deviation (SD) Coefficient of variation (% CV) 
Hydroquinon 1.40 18.38 8160.72 0.000 271.62 0.46 
Bethametasone 1.10 20.43 7340.56 2.651 331.11 0.35 
Tretinoin 0.85 11.18 13410.66 18.654 9647.61 0.75 
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Validation of analysis methods 
Calibration curve and linearity test 
Based on linear regression calculation, the equation of calibration 
curve line on hydroquinone compound y = 24020x+498795, 
tretinoin compound y = 119722x+19932, and betamethasone y = 
48433x-17671, where x is the concentration of hydroquinone, 
tretinoin or betamethasone and y is the area peak hydroquinone, 
tretinoin or betamethasone. Linearity is a measurement method to 
see how well the response relationship of various concentrations on 
a calibration curve to produce a straight line. The result of linearity 
test of hydroquinone solution in standard with range 50-300 μg/ml 
yielded correlation coefficient (r) equal to 0.9999, while the 
tretinoin linearity test within the standard with a range of 0.5-5 
μg/ml yielded a correlation coefficient (r) of 0.9994, and 
betamethasone linearity test in standard with range 1-20 μg/ml 
yielded correlation coefficient (r) equal to 0.9995. It can be 
concluded that the three calibration curves meet the linearity test as 
it yields a correlation coefficient (r) greater than or equal to 0.999 (≥ 
0.999). 
The purpose of the development of the method mainly is to 
determine the misuse of these ingredients in cosmetics products. 
The need to develop low LOD and LOQ is because the usual dose of 
this ingredient in cosmetics is relatively low. Smaller LOD and LOQ 
indicate that this method is able to identify and measure even in low 
concentrations. The LOD and LOQ for hydroquinone was 6.86 μg/ml 
and 22.89 μg/ml respectively, while LOD and LOQ for tretinoin was 
0.18 μg/ml and 0.61 μg/ml respectively, and the LOD and LOQ for 
the betamethasone was 0.71 μg/ml and 2.39 μg/ml respectively. The 
summary is shown in table 6. 
 
Table 6: Summary of validation 
Parameter Hydroquinone Betamethasone Tretionin 
Linearity y = 24020x+498795 
r = 0.9999 
y = 48433x–17671 
r=0.9995 
y = 119722x+19932 
r = 0.9995 
Recovery (%) 99.63-99.92 99.51-100.02 99.62-100.08 
Precision (%CV) 0.20-0.49 0.27-0.55 0.23-0.47 
LOD (µg/ml) 6.86 0.71 0.18 
LOQ (µg/ml) 22.89 2.39 0.61 
 
The retention times of hydroquinone, tretinoin and betamethasone 
respectively were 3.3 min, 8.0 min, and 3.8 min. The injection of 20.0 
μl of placebo solution (cream matrix) treated as in the preparation of 
the sample showed no interference at the time of retention of 
hydroquinone, tretinoin or betamethasone. This may prove that the 
method was selective to determine these three ingredients. 
Based on the results of the analysis, the average recovery value (% 
recovery) on three different concentrations for hydroquinone is 
80% (99.76%), 100% (99.63%), 120% (99.92%), tretinoin is 80% 
(100.08%), 100% (99.82%), 120% (99.62%), and for 
betamethasone that is 80% (99.51%), 100% (99.69%), 120% 
(100.02%). This result showed that the method was met the 
requirement in ICH, which with each of six replicas at each 
concentration meeting the 98-102% criterion. 
Furthermore, the value of the coefficient of variation (CV) for 
hydroquinone, tretinoin and betamethasone was approximately 0.20-
0.49%, 0.23-0.47%, and 0.27-0.55%. The precisions of the method were 
found to be satisfactory as the RSD values determined by repeatability 
and intermediate precision studies were all less than 2.0%. 
Analysis of whitening cream sample 
From 7 samples that was collected from the market an social media, 
two of them were positive contains hydroquinone, tretinoin, and 
betamethasone.
  
Table 7: Determination of hydroquinone, betamethasone and tretinoin levels in 1 mg skin whitening cream 
Sample Analyte Response detector Concentration of detected analyte 
(µV/s) (µg/ml) % 
A Hydroquinone 3923712 142.58 1.78 
Betamethasone 448923 9.63 0.12 
Tretinoin 699876 5.67 0.07 
B Hydroquinone 4325306 159.30 1.99 
Betamethasone 488161 10.44 0.13 
Tretinoin 797094 6.49 0.08 
 
DISCUSSION 
Hydroquinone, betamethasone and retinoic acid are forbidden to be 
used in cosmetics preparation due to its harmful effect on the skin. 
Despite that fact, those illegal ingredients are often found in cosmetics, 
especially, cosmetics that are not legally registered. These cosmetics 
are often found in the traditional market or sold via online shop [16]. 
Thus, the simple and rapid method to identify the presence of these 
illicit compounds is needed to be developed for market survey control. 
In the present study, HPLC was used for the qualitative and 
quantitative determination of hydroquinone, betamethasone, and 
tretinoin simultaneously from skin whitening cream. 
The choice of composition and mobile phase combination is 
essential in the initial step of optimizing the analysis conditions. The 
objective of this optimization was to obtain good separation 
characteristics, resolution, selective and generates a good area of the 
analyte. Generally, In the separation with reversed phase HPLC, the 
mobile phase used tends to be more polar (more hydrophilic) than 
the surface of the stationary phase. Based on the separation system 
used, the most polar hydroquinone will elute first and then be 
followed by betamethasone and the last is tretinoin which is the 
most non-polar [18-19]. Experiments with the mobile phase 
Acetonitrile-Methanol (90:10 v/v) resulted in better separation, 
sharp peaks, larger areas, faster retention times, and resolutions 
meeting the requirements. pH was adjusted to pH 5 by adding glacial 
acetic acid P to generates sharper peak. Selection of glacial acetic 
acid P as a pH modifier due to its better performance than other 
types of acids and is often used with acetonitrile and methanol [20]. 
In addition, glacial acetic acid resulted in better efficiency to 
increase the resolution between three compounds and sharpen the 
peak [20].  
The results of the validation assay of the mixture are within 
acceptable limits. Good linearity was observed in the concentration 
range employed in the test with a regression coefficient of more than 
0.9990. The coefficient correlation of those three active substances 
was low, being less than CV max. Thus the method is precise. 
Selectivity test was carried out by injecting 20 µl of the standard 
solution of hydroquinone, tretinoin, and betamethasone and 
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compared to the blank matrix. The results obtained did not show 
any interference at the retention time of hydroquinone, tretinoin, 
and betamethasone. The developed, validated method was applied 
for the 6 commercial cosmetic products. According to the Indonesian 
Ministry of Food and Drug safety, does not allow for the existence of 
hydroquinone, tretinoin, and betamethasone in whitening cosmetics 
[21-22]. As compiled in table 8, From 7 samples that were collected 
from the market and social media, two of them were positive 
contains hydroquinone, tretinoin, and betamethasone. Overall, the 
results showed that the proposed method could be successfully 
applied for the determination of cosmetic formulation containing 
hydroquinone, tretinoin, and betamethasone simultaneously. 
CONCLUSION  
Optimum conditions for the analysis of hydroquinone, tretinoin and 
betamethasone in cosmetic preparations using Reverse Phase 
Chromatography with UV-Vis detector, SunFireTM C18 column 
(column length 250 mm, inner diameter 4.6 mm, 5 μm particle size), 
using mobile phase composition acetonitrile-ethanol (90:10 v/v), 
wavelengths of 270 nm and 350 nm, and flow rate of 0.8 ml/min. An 
injection volume of 20.0 μl. The analysis method used fulfilled all 
validation criteria of analysis method consisting of selectivity test, 
linearity test, accuracy test, and precision test so that the method 
used is valid. Of the seven samples of whitening cream analyzed, two 
samples of them positively contained hydroquinone, tretinoin and 
betamethasone. In sample A, we have obtained hydroquinone, 
tretinoin and betamethasone levels respectively, 1.78%; 0.07% and 
0.12%. In sample B, we have obtained the levels of hydroquinone, 
tretinoin and betamethasone respectively, 2.00%; 0.07% and 0.13%. 
Both samples were obtained from social media. 
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